These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Thrombolytic therapy for acute myocardial infarction.
    Author: Meister FL, Stringer KA, Spinler SA, Gonzalez E, Talbert RL, Weiner B, Guerrero RM, Smith R.
    Journal: Pharmacotherapy; 1998; 18(4):686-98. PubMed ID: 9692643.
    Abstract:
    Numerous factors must be considered when determining the formulary status of thrombolytic agents for the treatment of acute myocardial infarction. Defined treatment options, predicted outcomes, and the economic consequences of this disorder continue to evolve from clinical trials. Pharmacists have a major role in delivering patient care, with responsibility for evaluating, procuring, and monitoring thrombolytic agents and drug therapy in general. By participating in the development and implementation of treatment guidelines, evaluating economic and therapeutic outcomes, providing timely optimal drug therapy, and educating health care providers and the public, they contribute significantly to the health care team.
    [Abstract] [Full Text] [Related] [New Search]